Wellesley Hills, MA – According to filings with the U.S. Securities and Exchange Commission, Intera Oncology is raising $5,000,000.00 in new funding. Sources indicate as part of senior management Founder, Jonathan Reis played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Intera Oncology

Intera Oncology is dedicated to substantially improving the survival of colorectal cancer and cholangiocarcinoma patients. Intera is a Boston based medical device company seeking to improve the treatment of patients with cancers of the liver. Intera Oncology has acquired Drug Delivery products from Johnson & Johnson to support HAI (hepatic artery infusion) therapy.

To learn more about Intera Oncology, visit http://www.interaoncology.com/

Contact:
Jonathan Reis, Founder
781-489-5724
https://www.linkedin.com/in/jonathan-reis-md-mba-3bb39311/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved